Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis

BACKGROUND: Verification of cerebrospinal fluid (CSF) biomarkers for multiple sclerosis and other neurological diseases is a major challenge due to a large number of candidates, limited sample material availability, disease and biological heterogeneity, and the lack of standardized assays. Furthermo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Proteomics
Egile Nagusiak: Guldbrandsen, Astrid, Lereim, Ragnhild Reehorst, Jacobsen, Mari, Garberg, Hilde, Kroksveen, Ann Cathrine, Barsnes, Harald, Berven, Frode S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499868/
https://ncbi.nlm.nih.gov/pubmed/32963504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09296-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak